Cita APA (7a ed.)

Dohrn, M. F., Medina, J., Dague, K. R. O., & Hund, E. (2021). Are we creating a new phenotype? Physiological barriers and ethical considerations in the treatment of hereditary transthyretin-amyloidosis. BMC.

Cita Chicago Style (17a ed.)

Dohrn, Maike F., Jessica Medina, Karmele R. Olaciregui Dague, y Ernst Hund. Are We Creating a New Phenotype? Physiological Barriers and Ethical Considerations in the Treatment of Hereditary Transthyretin-amyloidosis. BMC, 2021.

Cita MLA (8a ed.)

Dohrn, Maike F., et al. Are We Creating a New Phenotype? Physiological Barriers and Ethical Considerations in the Treatment of Hereditary Transthyretin-amyloidosis. BMC, 2021.